299 - APPLICATION OF OBESITY TREATMENT ALGORITHMS TO THE CANADIAN POPULATION
C Mason, CI Ardern, PT Katzmarzyk
Kingston, Ontario

300 - LEAD TO PULSE GENERATOR FAILURE RATIOS AS A MEASURE OF PRODUCT RELIABILITY
GF Tyers, J Clark, M Gao, RG Hauser
Vancouver, British Columbia

301 - N-ACETYLCYSTEINE IN ACUTE CORONARY SYNDROMES
RA Seyon, LA Jensen, IA Ferguson, RG Williams
Edmonton, Alberta

302 - BURDEN OF CARDIOVASCULAR DISEASES IN CANADA
AM Ugnat, W Luo, Y Mao
Ottawa, Ontario

303 - INDIVIDUAL-LEVEL AND NEIGHBOURHOOD-LEVEL INCOME MEASURES: AGREEMENT AND ASSOCIATION WITH OUTCOMES IN A CARDIAC DISEASE COHORT
DA Southern, L McLaren, P Hawe, ML Knudtson, WA Ghali
Calgary, Alberta

304 - HEART FAILURE PATIENTS ACCESSING ACUTE CARE HOSPITALS: WHERE DO THEY COME FROM? A POPULATION BASED STUDY
ET Tjam, SJ Smith, JP Hirdes, J Poss, D Pletz, AB Arai
Kitchener, Ontario; Toronto, Ontario

305 - ARE STATINS CREATED EQUAL? – EVIDENCE FROM RANDOMIZED TRIALS OF PRAVASTATIN, SIMVASTATIN AND ATORVASTATIN FOR CARDIOVASCULAR DISEASE PREVENTION
Z Zhou, E Rahme, L Pilote
Montreal, Quebec

306 - REGIONAL VARIATION IN THE METABOLIC SYNDROME IN CANADA
CI Ardern, PT Katzmarzyk
Kingston, Ontario